Novoron Bioscience, Inc. reported raising $3.03 Million in an initial SEC Form D filing, from an offering of $3.03 Million
Amount Raised
$3.03 Million
Round Type
Seed
Quick answer
Novoron Bioscience raised $3.03 Million in a Seed round, dated July 8, 2021. Novoron Bioscience is based in San Diego, California, United States.
- How much did Novoron Bioscience raise?
- Novoron Bioscience raised $3.03 Million in a Seed round on July 8, 2021.
- What does Novoron Bioscience do?
- Novoron Bioscience is a biotechnology company pioneering lipoprotein-receptor drug development to repair damage and degeneration to the brain, spinal cord and beyond.
- Where is Novoron Bioscience based and how big is it?
- Novoron Bioscience is based in San Diego, California, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Novoron Bioscience that raised within 45 days of this round, from Fundz verified event records.
- Ambagon Therapeutics raised $5.4M on August 20, 2021.
- Circular Genomics raised $3.1M on August 20, 2021.
- Nobell Foods raised $27M on August 20, 2021.
- Opus Genetics raised $9.5M on August 20, 2021.
- Gross-Wen Technologies raised $6.5M on August 20, 2021.
- Evecxia raised $8.6M on August 20, 2021.
Who to call at Novoron Bioscience, and when
A new round usually means Novoron Bioscience is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Novoron Bioscience raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Novoron Bioscience, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Novoron Bioscience. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Novoron Bioscience raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Novoron Bioscience raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.